
Dividend history
Big Pharma Split Corp Class A
PRM.TO
Recent payments
$0.1031CAD
Ex: Sep 29, 2026
Pay: Oct 6
$0.1030CAD
Ex: Jul 31, 2026
Pay: Aug 6
$0.1030CAD
Ex: Jun 30, 2026
$0.1030CAD
Ex: May 29, 2026
$0.1030CAD
Ex: Feb 27, 2026
$0.1030CAD
Ex: Jan 30, 2026
$0.1030CAD
Ex: Dec 31, 2025
Pay: Jan 6
$0.1030CAD
Ex: Nov 28, 2025
Pay: Dec 5
$0.1030CAD
Ex: Oct 31, 2025
Pay: Nov 6
$0.1030CAD
Ex: Sep 29, 2025
Pay: Oct 9
Big Pharma Split Corp Class A has raised its dividend.
Big Pharma Split Corp Class A (PRM.TO) announced an increase in its monthly dividend from CA$0.103 to CA$0.1031. This is the second time the company has raised its dividend in three years.
Advertisement
Big Pharma Split Corp Class A
PRM.TO
PRM.TO
Big Pharma Split Corp Class A
Market cap
$18.78M
Div. yield
8.81%
Div. / share
$1.24
52W high
$15.89
52W low
$10.79
1W change
-5.36%
Beta
0.73
Analyst Price Targets
Based on analyst covering PRM · as of Sep 17, 2026
Wall Street analysts forecast PRM stock price to fall 86.0% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.00
-86.0% Upside
Current Price
C$14.30
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRM's historical volatility
30-Day Vol
38.7%
Annualized
90-Day Vol
30.7%
Annualized
Trend (90d)
-6.7%
Annualized drift
90d Mean
C$13.96
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$14.19 | C$12.41 – C$16.21 |
| 60 trading days | C$14.07 | C$11.65 – C$17.00 |
| 90 trading days | C$13.96 | C$11.08 – C$17.60 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The new dividend amount shows the company's commitment to returning value to shareholders. Canadian investors can receive this dividend in registered accounts like TFSA or RRSP, which may offer tax benefits.
New Dividend Amount: CA$0.1031
Prior Dividend Amount: CA$0.103
Dividend Details
Advertisement
The recent increase in the dividend for Big Pharma Split Corp Class A is now CA$0.1031 per share, up from CA$0.103. This change was declared on September 23, 2026, with the ex-dividend date set for September 29, 2026, and payment occurring today, October 6, 2026. This monthly dividend is part of the company's ongoing strategy to provide returns to shareholders.
Dividend History
Big Pharma Split Corp Class A has a solid track record of dividend payments, with 36 payments made over about 3.1 years. This includes two dividend increases, highlighting the company's focus on enhancing shareholder value. While the recent increase is modest, it reflects a positive trend in the company's financial management.
Dividend calendar
| Ticker | PRM.TO |
| Amount | CA$0.1031 |
| Ex-dividend | 2026-09-29 |
| Record | 2026-09-29 |
| Payment | 2026-10-06 |
| Declared | 2026-09-23 |
| Trailing yield | 8.81% |
| Stock page | PRM.TO dividend history |
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement

Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

